The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global FDF of UDCA and t-UDCA Market Research Report 2025
Synopsis
Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis.
The global FDF of UDCA and t-UDCA market was valued at US$ 1704 million in 2023 and is anticipated to reach US$ 3754.5 million by 2030, witnessing a CAGR of 12.1% during the forecast period 2024-2030.
The FDF (Finished Dosage Form) market of UDCA (Ursodeoxycholic Acid) and t-UDCA (Tauroursodeoxycholic Acid) is driven by the increasing recognition of these bile acids for their therapeutic potential in treating liver and gallbladder disorders. UDCA and t-UDCA have demonstrated hepatoprotective properties and are used to manage conditions such as primary biliary cholangitis, non-alcoholic fatty liver disease, and gallstones. The growing prevalence of liver-related diseases and the need for effective treatments that address underlying causes contribute to market growth, as healthcare professionals and patients seek reliable options that improve liver function and overall health. Moreover, advancements in drug formulation and delivery systems, as well as research on optimizing therapeutic dosages, align with the development of convenient and effective FDFs, fostering market adoption. However, the market also faces challenges, including regulatory approvals, ensuring bioavailability and stability of the active compounds, and addressing potential side effects. Additionally, market competitiveness and the need for continuous research to demonstrate the clinical benefits of UDCA and t-UDCA in various liver conditions pose obstacles for manufacturers and researchers. To succeed, stakeholders must focus on formulation innovation, comprehensive clinical studies, and addressing the challenges to provide healthcare professionals with reliable and effective FDFs of UDCA and t-UDCA that contribute to improved liver health and patient outcomes, while maintaining safety and efficacy standards.
This report aims to provide a comprehensive presentation of the global market for FDF of UDCA and t-UDCA, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding FDF of UDCA and t-UDCA.
Report Scope
The FDF of UDCA and t-UDCA market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global FDF of UDCA and t-UDCA market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the FDF of UDCA and t-UDCA manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Dr. Falk Pharma
Daewoong Pharmaceutical
Teva
Epic Pharma
Mitsubishi Tanabe Pharma
Lannett
Mylan
Bruschettini
Impax
Shanghai Pharma
Grindeks
Bruschettini
Nutricost
BodyBio
Double Wood Supplements
Vitaceutico
Segment by Type
t-UDCA
UDCA
Segment by Application
Gallstone
Hepatopathy
Biliary Disease
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of FDF of UDCA and t-UDCA manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of FDF of UDCA and t-UDCA in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Ursodeoxycholic Acid is an important clinical drug in the treatment of gallstones, cholecystitis, PBC, and PSC and has broad market prospects. In previous work, ursodeoxycholic acid was prepared by traditional organic synthesis.
The global FDF of UDCA and t-UDCA market was valued at US$ 1704 million in 2023 and is anticipated to reach US$ 3754.5 million by 2030, witnessing a CAGR of 12.1% during the forecast period 2024-2030.
The FDF (Finished Dosage Form) market of UDCA (Ursodeoxycholic Acid) and t-UDCA (Tauroursodeoxycholic Acid) is driven by the increasing recognition of these bile acids for their therapeutic potential in treating liver and gallbladder disorders. UDCA and t-UDCA have demonstrated hepatoprotective properties and are used to manage conditions such as primary biliary cholangitis, non-alcoholic fatty liver disease, and gallstones. The growing prevalence of liver-related diseases and the need for effective treatments that address underlying causes contribute to market growth, as healthcare professionals and patients seek reliable options that improve liver function and overall health. Moreover, advancements in drug formulation and delivery systems, as well as research on optimizing therapeutic dosages, align with the development of convenient and effective FDFs, fostering market adoption. However, the market also faces challenges, including regulatory approvals, ensuring bioavailability and stability of the active compounds, and addressing potential side effects. Additionally, market competitiveness and the need for continuous research to demonstrate the clinical benefits of UDCA and t-UDCA in various liver conditions pose obstacles for manufacturers and researchers. To succeed, stakeholders must focus on formulation innovation, comprehensive clinical studies, and addressing the challenges to provide healthcare professionals with reliable and effective FDFs of UDCA and t-UDCA that contribute to improved liver health and patient outcomes, while maintaining safety and efficacy standards.
This report aims to provide a comprehensive presentation of the global market for FDF of UDCA and t-UDCA, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding FDF of UDCA and t-UDCA.
Report Scope
The FDF of UDCA and t-UDCA market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global FDF of UDCA and t-UDCA market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the FDF of UDCA and t-UDCA manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Dr. Falk Pharma
Daewoong Pharmaceutical
Teva
Epic Pharma
Mitsubishi Tanabe Pharma
Lannett
Mylan
Bruschettini
Impax
Shanghai Pharma
Grindeks
Bruschettini
Nutricost
BodyBio
Double Wood Supplements
Vitaceutico
Segment by Type
t-UDCA
UDCA
Segment by Application
Gallstone
Hepatopathy
Biliary Disease
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of FDF of UDCA and t-UDCA manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of FDF of UDCA and t-UDCA in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 FDF of UDCA and t-UDCA Market Overview
1.1 Product Overview and Scope of FDF of UDCA and t-UDCA
1.2 FDF of UDCA and t-UDCA Segment by Type
1.2.1 Global FDF of UDCA and t-UDCA Market Value Comparison by Type (2024-2030)
1.2.2 t-UDCA
1.2.3 UDCA
1.3 FDF of UDCA and t-UDCA Segment by Application
1.3.1 Global FDF of UDCA and t-UDCA Market Value by Application: (2024-2030)
1.3.2 Gallstone
1.3.3 Hepatopathy
1.3.4 Biliary Disease
1.3.5 Other
1.4 Global FDF of UDCA and t-UDCA Market Size Estimates and Forecasts
1.4.1 Global FDF of UDCA and t-UDCA Revenue 2019-2030
1.4.2 Global FDF of UDCA and t-UDCA Sales 2019-2030
1.4.3 Global FDF of UDCA and t-UDCA Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 FDF of UDCA and t-UDCA Market Competition by Manufacturers
2.1 Global FDF of UDCA and t-UDCA Sales Market Share by Manufacturers (2019-2024)
2.2 Global FDF of UDCA and t-UDCA Revenue Market Share by Manufacturers (2019-2024)
2.3 Global FDF of UDCA and t-UDCA Average Price by Manufacturers (2019-2024)
2.4 Global FDF of UDCA and t-UDCA Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of FDF of UDCA and t-UDCA, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of FDF of UDCA and t-UDCA, Product Type & Application
2.7 FDF of UDCA and t-UDCA Market Competitive Situation and Trends
2.7.1 FDF of UDCA and t-UDCA Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest FDF of UDCA and t-UDCA Players Market Share by Revenue
2.7.3 Global FDF of UDCA and t-UDCA Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 FDF of UDCA and t-UDCA Retrospective Market Scenario by Region
3.1 Global FDF of UDCA and t-UDCA Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global FDF of UDCA and t-UDCA Global FDF of UDCA and t-UDCA Sales by Region: 2019-2030
3.2.1 Global FDF of UDCA and t-UDCA Sales by Region: 2019-2024
3.2.2 Global FDF of UDCA and t-UDCA Sales by Region: 2025-2030
3.3 Global FDF of UDCA and t-UDCA Global FDF of UDCA and t-UDCA Revenue by Region: 2019-2030
3.3.1 Global FDF of UDCA and t-UDCA Revenue by Region: 2019-2024
3.3.2 Global FDF of UDCA and t-UDCA Revenue by Region: 2025-2030
3.4 North America FDF of UDCA and t-UDCA Market Facts & Figures by Country
3.4.1 North America FDF of UDCA and t-UDCA Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America FDF of UDCA and t-UDCA Sales by Country (2019-2030)
3.4.3 North America FDF of UDCA and t-UDCA Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe FDF of UDCA and t-UDCA Market Facts & Figures by Country
3.5.1 Europe FDF of UDCA and t-UDCA Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe FDF of UDCA and t-UDCA Sales by Country (2019-2030)
3.5.3 Europe FDF of UDCA and t-UDCA Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific FDF of UDCA and t-UDCA Market Facts & Figures by Country
3.6.1 Asia Pacific FDF of UDCA and t-UDCA Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific FDF of UDCA and t-UDCA Sales by Country (2019-2030)
3.6.3 Asia Pacific FDF of UDCA and t-UDCA Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America FDF of UDCA and t-UDCA Market Facts & Figures by Country
3.7.1 Latin America FDF of UDCA and t-UDCA Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America FDF of UDCA and t-UDCA Sales by Country (2019-2030)
3.7.3 Latin America FDF of UDCA and t-UDCA Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa FDF of UDCA and t-UDCA Market Facts & Figures by Country
3.8.1 Middle East and Africa FDF of UDCA and t-UDCA Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa FDF of UDCA and t-UDCA Sales by Country (2019-2030)
3.8.3 Middle East and Africa FDF of UDCA and t-UDCA Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global FDF of UDCA and t-UDCA Sales by Type (2019-2030)
4.1.1 Global FDF of UDCA and t-UDCA Sales by Type (2019-2024)
4.1.2 Global FDF of UDCA and t-UDCA Sales by Type (2025-2030)
4.1.3 Global FDF of UDCA and t-UDCA Sales Market Share by Type (2019-2030)
4.2 Global FDF of UDCA and t-UDCA Revenue by Type (2019-2030)
4.2.1 Global FDF of UDCA and t-UDCA Revenue by Type (2019-2024)
4.2.2 Global FDF of UDCA and t-UDCA Revenue by Type (2025-2030)
4.2.3 Global FDF of UDCA and t-UDCA Revenue Market Share by Type (2019-2030)
4.3 Global FDF of UDCA and t-UDCA Price by Type (2019-2030)
5 Segment by Application
5.1 Global FDF of UDCA and t-UDCA Sales by Application (2019-2030)
5.1.1 Global FDF of UDCA and t-UDCA Sales by Application (2019-2024)
5.1.2 Global FDF of UDCA and t-UDCA Sales by Application (2025-2030)
5.1.3 Global FDF of UDCA and t-UDCA Sales Market Share by Application (2019-2030)
5.2 Global FDF of UDCA and t-UDCA Revenue by Application (2019-2030)
5.2.1 Global FDF of UDCA and t-UDCA Revenue by Application (2019-2024)
5.2.2 Global FDF of UDCA and t-UDCA Revenue by Application (2025-2030)
5.2.3 Global FDF of UDCA and t-UDCA Revenue Market Share by Application (2019-2030)
5.3 Global FDF of UDCA and t-UDCA Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Dr. Falk Pharma
6.1.1 Dr. Falk Pharma Corporation Information
6.1.2 Dr. Falk Pharma Description and Business Overview
6.1.3 Dr. Falk Pharma FDF of UDCA and t-UDCA Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Dr. Falk Pharma FDF of UDCA and t-UDCA Product Portfolio
6.1.5 Dr. Falk Pharma Recent Developments/Updates
6.2 Daewoong Pharmaceutical
6.2.1 Daewoong Pharmaceutical Corporation Information
6.2.2 Daewoong Pharmaceutical Description and Business Overview
6.2.3 Daewoong Pharmaceutical FDF of UDCA and t-UDCA Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Daewoong Pharmaceutical FDF of UDCA and t-UDCA Product Portfolio
6.2.5 Daewoong Pharmaceutical Recent Developments/Updates
6.3 Teva
6.3.1 Teva Corporation Information
6.3.2 Teva Description and Business Overview
6.3.3 Teva FDF of UDCA and t-UDCA Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Teva FDF of UDCA and t-UDCA Product Portfolio
6.3.5 Teva Recent Developments/Updates
6.4 Epic Pharma
6.4.1 Epic Pharma Corporation Information
6.4.2 Epic Pharma Description and Business Overview
6.4.3 Epic Pharma FDF of UDCA and t-UDCA Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Epic Pharma FDF of UDCA and t-UDCA Product Portfolio
6.4.5 Epic Pharma Recent Developments/Updates
6.5 Mitsubishi Tanabe Pharma
6.5.1 Mitsubishi Tanabe Pharma Corporation Information
6.5.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.5.3 Mitsubishi Tanabe Pharma FDF of UDCA and t-UDCA Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Mitsubishi Tanabe Pharma FDF of UDCA and t-UDCA Product Portfolio
6.5.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.6 Lannett
6.6.1 Lannett Corporation Information
6.6.2 Lannett Description and Business Overview
6.6.3 Lannett FDF of UDCA and t-UDCA Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Lannett FDF of UDCA and t-UDCA Product Portfolio
6.6.5 Lannett Recent Developments/Updates
6.7 Mylan
6.6.1 Mylan Corporation Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan FDF of UDCA and t-UDCA Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Mylan FDF of UDCA and t-UDCA Product Portfolio
6.7.5 Mylan Recent Developments/Updates
6.8 Bruschettini
6.8.1 Bruschettini Corporation Information
6.8.2 Bruschettini Description and Business Overview
6.8.3 Bruschettini FDF of UDCA and t-UDCA Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bruschettini FDF of UDCA and t-UDCA Product Portfolio
6.8.5 Bruschettini Recent Developments/Updates
6.9 Impax
6.9.1 Impax Corporation Information
6.9.2 Impax Description and Business Overview
6.9.3 Impax FDF of UDCA and t-UDCA Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Impax FDF of UDCA and t-UDCA Product Portfolio
6.9.5 Impax Recent Developments/Updates
6.10 Shanghai Pharma
6.10.1 Shanghai Pharma Corporation Information
6.10.2 Shanghai Pharma Description and Business Overview
6.10.3 Shanghai Pharma FDF of UDCA and t-UDCA Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Shanghai Pharma FDF of UDCA and t-UDCA Product Portfolio
6.10.5 Shanghai Pharma Recent Developments/Updates
6.11 Grindeks
6.11.1 Grindeks Corporation Information
6.11.2 Grindeks FDF of UDCA and t-UDCA Description and Business Overview
6.11.3 Grindeks FDF of UDCA and t-UDCA Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Grindeks FDF of UDCA and t-UDCA Product Portfolio
6.11.5 Grindeks Recent Developments/Updates
6.12 Bruschettini
6.12.1 Bruschettini Corporation Information
6.12.2 Bruschettini FDF of UDCA and t-UDCA Description and Business Overview
6.12.3 Bruschettini FDF of UDCA and t-UDCA Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Bruschettini FDF of UDCA and t-UDCA Product Portfolio
6.12.5 Bruschettini Recent Developments/Updates
6.13 Nutricost
6.13.1 Nutricost Corporation Information
6.13.2 Nutricost FDF of UDCA and t-UDCA Description and Business Overview
6.13.3 Nutricost FDF of UDCA and t-UDCA Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Nutricost FDF of UDCA and t-UDCA Product Portfolio
6.13.5 Nutricost Recent Developments/Updates
6.14 BodyBio
6.14.1 BodyBio Corporation Information
6.14.2 BodyBio FDF of UDCA and t-UDCA Description and Business Overview
6.14.3 BodyBio FDF of UDCA and t-UDCA Sales, Revenue and Gross Margin (2019-2024)
6.14.4 BodyBio FDF of UDCA and t-UDCA Product Portfolio
6.14.5 BodyBio Recent Developments/Updates
6.15 Double Wood Supplements
6.15.1 Double Wood Supplements Corporation Information
6.15.2 Double Wood Supplements FDF of UDCA and t-UDCA Description and Business Overview
6.15.3 Double Wood Supplements FDF of UDCA and t-UDCA Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Double Wood Supplements FDF of UDCA and t-UDCA Product Portfolio
6.15.5 Double Wood Supplements Recent Developments/Updates
6.16 Vitaceutico
6.16.1 Vitaceutico Corporation Information
6.16.2 Vitaceutico FDF of UDCA and t-UDCA Description and Business Overview
6.16.3 Vitaceutico FDF of UDCA and t-UDCA Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Vitaceutico FDF of UDCA and t-UDCA Product Portfolio
6.16.5 Vitaceutico Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 FDF of UDCA and t-UDCA Industry Chain Analysis
7.2 FDF of UDCA and t-UDCA Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 FDF of UDCA and t-UDCA Production Mode & Process
7.4 FDF of UDCA and t-UDCA Sales and Marketing
7.4.1 FDF of UDCA and t-UDCA Sales Channels
7.4.2 FDF of UDCA and t-UDCA Distributors
7.5 FDF of UDCA and t-UDCA Customers
8 FDF of UDCA and t-UDCA Market Dynamics
8.1 FDF of UDCA and t-UDCA Industry Trends
8.2 FDF of UDCA and t-UDCA Market Drivers
8.3 FDF of UDCA and t-UDCA Market Challenges
8.4 FDF of UDCA and t-UDCA Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global FDF of UDCA and t-UDCA Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global FDF of UDCA and t-UDCA Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global FDF of UDCA and t-UDCA Market Competitive Situation by Manufacturers in 2023
Table 4. Global FDF of UDCA and t-UDCA Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global FDF of UDCA and t-UDCA Sales Market Share by Manufacturers (2019-2024)
Table 6. Global FDF of UDCA and t-UDCA Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global FDF of UDCA and t-UDCA Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market FDF of UDCA and t-UDCA Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of FDF of UDCA and t-UDCA, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of FDF of UDCA and t-UDCA, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of FDF of UDCA and t-UDCA, Product Type & Application
Table 12. Global Key Manufacturers of FDF of UDCA and t-UDCA, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global FDF of UDCA and t-UDCA by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in FDF of UDCA and t-UDCA as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global FDF of UDCA and t-UDCA Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global FDF of UDCA and t-UDCA Sales by Region (2019-2024) & (K Units)
Table 18. Global FDF of UDCA and t-UDCA Sales Market Share by Region (2019-2024)
Table 19. Global FDF of UDCA and t-UDCA Sales by Region (2025-2030) & (K Units)
Table 20. Global FDF of UDCA and t-UDCA Sales Market Share by Region (2025-2030)
Table 21. Global FDF of UDCA and t-UDCA Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global FDF of UDCA and t-UDCA Revenue Market Share by Region (2019-2024)
Table 23. Global FDF of UDCA and t-UDCA Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global FDF of UDCA and t-UDCA Revenue Market Share by Region (2025-2030)
Table 25. North America FDF of UDCA and t-UDCA Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America FDF of UDCA and t-UDCA Sales by Country (2019-2024) & (K Units)
Table 27. North America FDF of UDCA and t-UDCA Sales by Country (2025-2030) & (K Units)
Table 28. North America FDF of UDCA and t-UDCA Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America FDF of UDCA and t-UDCA Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe FDF of UDCA and t-UDCA Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe FDF of UDCA and t-UDCA Sales by Country (2019-2024) & (K Units)
Table 32. Europe FDF of UDCA and t-UDCA Sales by Country (2025-2030) & (K Units)
Table 33. Europe FDF of UDCA and t-UDCA Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe FDF of UDCA and t-UDCA Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific FDF of UDCA and t-UDCA Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific FDF of UDCA and t-UDCA Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific FDF of UDCA and t-UDCA Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific FDF of UDCA and t-UDCA Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific FDF of UDCA and t-UDCA Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America FDF of UDCA and t-UDCA Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America FDF of UDCA and t-UDCA Sales by Country (2019-2024) & (K Units)
Table 42. Latin America FDF of UDCA and t-UDCA Sales by Country (2025-2030) & (K Units)
Table 43. Latin America FDF of UDCA and t-UDCA Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America FDF of UDCA and t-UDCA Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa FDF of UDCA and t-UDCA Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa FDF of UDCA and t-UDCA Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa FDF of UDCA and t-UDCA Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa FDF of UDCA and t-UDCA Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa FDF of UDCA and t-UDCA Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global FDF of UDCA and t-UDCA Sales (K Units) by Type (2019-2024)
Table 51. Global FDF of UDCA and t-UDCA Sales (K Units) by Type (2025-2030)
Table 52. Global FDF of UDCA and t-UDCA Sales Market Share by Type (2019-2024)
Table 53. Global FDF of UDCA and t-UDCA Sales Market Share by Type (2025-2030)
Table 54. Global FDF of UDCA and t-UDCA Revenue (US$ Million) by Type (2019-2024)
Table 55. Global FDF of UDCA and t-UDCA Revenue (US$ Million) by Type (2025-2030)
Table 56. Global FDF of UDCA and t-UDCA Revenue Market Share by Type (2019-2024)
Table 57. Global FDF of UDCA and t-UDCA Revenue Market Share by Type (2025-2030)
Table 58. Global FDF of UDCA and t-UDCA Price (US$/Unit) by Type (2019-2024)
Table 59. Global FDF of UDCA and t-UDCA Price (US$/Unit) by Type (2025-2030)
Table 60. Global FDF of UDCA and t-UDCA Sales (K Units) by Application (2019-2024)
Table 61. Global FDF of UDCA and t-UDCA Sales (K Units) by Application (2025-2030)
Table 62. Global FDF of UDCA and t-UDCA Sales Market Share by Application (2019-2024)
Table 63. Global FDF of UDCA and t-UDCA Sales Market Share by Application (2025-2030)
Table 64. Global FDF of UDCA and t-UDCA Revenue (US$ Million) by Application (2019-2024)
Table 65. Global FDF of UDCA and t-UDCA Revenue (US$ Million) by Application (2025-2030)
Table 66. Global FDF of UDCA and t-UDCA Revenue Market Share by Application (2019-2024)
Table 67. Global FDF of UDCA and t-UDCA Revenue Market Share by Application (2025-2030)
Table 68. Global FDF of UDCA and t-UDCA Price (US$/Unit) by Application (2019-2024)
Table 69. Global FDF of UDCA and t-UDCA Price (US$/Unit) by Application (2025-2030)
Table 70. Dr. Falk Pharma Corporation Information
Table 71. Dr. Falk Pharma Description and Business Overview
Table 72. Dr. Falk Pharma FDF of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Dr. Falk Pharma FDF of UDCA and t-UDCA Product
Table 74. Dr. Falk Pharma Recent Developments/Updates
Table 75. Daewoong Pharmaceutical Corporation Information
Table 76. Daewoong Pharmaceutical Description and Business Overview
Table 77. Daewoong Pharmaceutical FDF of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Daewoong Pharmaceutical FDF of UDCA and t-UDCA Product
Table 79. Daewoong Pharmaceutical Recent Developments/Updates
Table 80. Teva Corporation Information
Table 81. Teva Description and Business Overview
Table 82. Teva FDF of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Teva FDF of UDCA and t-UDCA Product
Table 84. Teva Recent Developments/Updates
Table 85. Epic Pharma Corporation Information
Table 86. Epic Pharma Description and Business Overview
Table 87. Epic Pharma FDF of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Epic Pharma FDF of UDCA and t-UDCA Product
Table 89. Epic Pharma Recent Developments/Updates
Table 90. Mitsubishi Tanabe Pharma Corporation Information
Table 91. Mitsubishi Tanabe Pharma Description and Business Overview
Table 92. Mitsubishi Tanabe Pharma FDF of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Mitsubishi Tanabe Pharma FDF of UDCA and t-UDCA Product
Table 94. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 95. Lannett Corporation Information
Table 96. Lannett Description and Business Overview
Table 97. Lannett FDF of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Lannett FDF of UDCA and t-UDCA Product
Table 99. Lannett Recent Developments/Updates
Table 100. Mylan Corporation Information
Table 101. Mylan Description and Business Overview
Table 102. Mylan FDF of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Mylan FDF of UDCA and t-UDCA Product
Table 104. Mylan Recent Developments/Updates
Table 105. Bruschettini Corporation Information
Table 106. Bruschettini Description and Business Overview
Table 107. Bruschettini FDF of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Bruschettini FDF of UDCA and t-UDCA Product
Table 109. Bruschettini Recent Developments/Updates
Table 110. Impax Corporation Information
Table 111. Impax Description and Business Overview
Table 112. Impax FDF of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Impax FDF of UDCA and t-UDCA Product
Table 114. Impax Recent Developments/Updates
Table 115. Shanghai Pharma Corporation Information
Table 116. Shanghai Pharma Description and Business Overview
Table 117. Shanghai Pharma FDF of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Shanghai Pharma FDF of UDCA and t-UDCA Product
Table 119. Shanghai Pharma Recent Developments/Updates
Table 120. Grindeks Corporation Information
Table 121. Grindeks Description and Business Overview
Table 122. Grindeks FDF of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Grindeks FDF of UDCA and t-UDCA Product
Table 124. Grindeks Recent Developments/Updates
Table 125. Bruschettini Corporation Information
Table 126. Bruschettini Description and Business Overview
Table 127. Bruschettini FDF of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Bruschettini FDF of UDCA and t-UDCA Product
Table 129. Bruschettini Recent Developments/Updates
Table 130. Nutricost Corporation Information
Table 131. Nutricost Description and Business Overview
Table 132. Nutricost FDF of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Nutricost FDF of UDCA and t-UDCA Product
Table 134. Nutricost Recent Developments/Updates
Table 135. BodyBio Corporation Information
Table 136. BodyBio Description and Business Overview
Table 137. BodyBio FDF of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. BodyBio FDF of UDCA and t-UDCA Product
Table 139. BodyBio Recent Developments/Updates
Table 140. Double Wood Supplements Corporation Information
Table 141. Double Wood Supplements Description and Business Overview
Table 142. Double Wood Supplements FDF of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Double Wood Supplements FDF of UDCA and t-UDCA Product
Table 144. Double Wood Supplements Recent Developments/Updates
Table 145. Vitaceutico Corporation Information
Table 146. Vitaceutico Description and Business Overview
Table 147. Vitaceutico FDF of UDCA and t-UDCA Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Vitaceutico FDF of UDCA and t-UDCA Product
Table 149. Vitaceutico Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. FDF of UDCA and t-UDCA Distributors List
Table 153. FDF of UDCA and t-UDCA Customers List
Table 154. FDF of UDCA and t-UDCA Market Trends
Table 155. FDF of UDCA and t-UDCA Market Drivers
Table 156. FDF of UDCA and t-UDCA Market Challenges
Table 157. FDF of UDCA and t-UDCA Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of FDF of UDCA and t-UDCA
Figure 2. Global FDF of UDCA and t-UDCA Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global FDF of UDCA and t-UDCA Market Share by Type in 2023 & 2030
Figure 4. t-UDCA Product Picture
Figure 5. UDCA Product Picture
Figure 6. Global FDF of UDCA and t-UDCA Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global FDF of UDCA and t-UDCA Market Share by Application in 2023 & 2030
Figure 8. Gallstone
Figure 9. Hepatopathy
Figure 10. Biliary Disease
Figure 11. Other
Figure 12. Global FDF of UDCA and t-UDCA Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global FDF of UDCA and t-UDCA Market Size (2019-2030) & (US$ Million)
Figure 14. Global FDF of UDCA and t-UDCA Sales (2019-2030) & (K Units)
Figure 15. Global FDF of UDCA and t-UDCA Average Price (US$/Unit) & (2019-2030)
Figure 16. FDF of UDCA and t-UDCA Report Years Considered
Figure 17. FDF of UDCA and t-UDCA Sales Share by Manufacturers in 2023
Figure 18. Global FDF of UDCA and t-UDCA Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest FDF of UDCA and t-UDCA Players: Market Share by Revenue in 2023
Figure 20. FDF of UDCA and t-UDCA Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global FDF of UDCA and t-UDCA Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America FDF of UDCA and t-UDCA Sales Market Share by Country (2019-2030)
Figure 23. North America FDF of UDCA and t-UDCA Revenue Market Share by Country (2019-2030)
Figure 24. U.S. FDF of UDCA and t-UDCA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada FDF of UDCA and t-UDCA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe FDF of UDCA and t-UDCA Sales Market Share by Country (2019-2030)
Figure 27. Europe FDF of UDCA and t-UDCA Revenue Market Share by Country (2019-2030)
Figure 28. Germany FDF of UDCA and t-UDCA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France FDF of UDCA and t-UDCA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. FDF of UDCA and t-UDCA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy FDF of UDCA and t-UDCA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia FDF of UDCA and t-UDCA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific FDF of UDCA and t-UDCA Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific FDF of UDCA and t-UDCA Revenue Market Share by Region (2019-2030)
Figure 35. China FDF of UDCA and t-UDCA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan FDF of UDCA and t-UDCA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea FDF of UDCA and t-UDCA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India FDF of UDCA and t-UDCA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia FDF of UDCA and t-UDCA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan FDF of UDCA and t-UDCA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia FDF of UDCA and t-UDCA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand FDF of UDCA and t-UDCA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia FDF of UDCA and t-UDCA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines FDF of UDCA and t-UDCA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America FDF of UDCA and t-UDCA Sales Market Share by Country (2019-2030)
Figure 46. Latin America FDF of UDCA and t-UDCA Revenue Market Share by Country (2019-2030)
Figure 47. Mexico FDF of UDCA and t-UDCA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil FDF of UDCA and t-UDCA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina FDF of UDCA and t-UDCA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa FDF of UDCA and t-UDCA Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa FDF of UDCA and t-UDCA Revenue Market Share by Country (2019-2030)
Figure 52. Turkey FDF of UDCA and t-UDCA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia FDF of UDCA and t-UDCA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. U.A.E FDF of UDCA and t-UDCA Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of FDF of UDCA and t-UDCA by Type (2019-2030)
Figure 56. Global Revenue Market Share of FDF of UDCA and t-UDCA by Type (2019-2030)
Figure 57. Global FDF of UDCA and t-UDCA Price (US$/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of FDF of UDCA and t-UDCA by Application (2019-2030)
Figure 59. Global Revenue Market Share of FDF of UDCA and t-UDCA by Application (2019-2030)
Figure 60. Global FDF of UDCA and t-UDCA Price (US$/Unit) by Application (2019-2030)
Figure 61. FDF of UDCA and t-UDCA Value Chain
Figure 62. FDF of UDCA and t-UDCA Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
